Taliglucerase alfa
DrugBank ID: DB08876
Summary
| Metric | Value |
|---|---|
| Total Predictions | 50 |
| KG+DL (Dual Validated) | 1 |
| DL Only | 49 |
| KG Only | 0 |
Predictions
| Indication | Score | Source |
|---|---|---|
| Hurler syndrome | 0.9952 | DL |
| Gaucher disease | 0.9940 | KG+DL |
| Scheie syndrome | 0.9929 | DL |
| benign neoplasm of adrenal gland | 0.9928 | DL |
| autosomal ichthyosis syndrome with fatal disease course | 0.9924 | DL |
| cholesteryl ester storage disease | 0.9912 | DL |
| lysosomal storage disease with skeletal involvement | 0.9894 | DL |
| Wolman disease with hypolipoproteinemia and acanthocytosis | 0.9893 | DL |
| Wolman disease | 0.9878 | DL |
| proximal myopathy with extrapyramidal signs | 0.9854 | DL |
| growth hormone insensitivity syndrome with immune dysregulation 2, autosomal dominant | 0.9849 | DL |
| Tay-Sachs disease | 0.9841 | DL |
| familial apolipoprotein C-II deficiency | 0.9837 | DL |
| adult Krabbe disease | 0.9836 | DL |
| encephalopathy due to prosaposin deficiency | 0.9830 | DL |
| Krabbe disease | 0.9815 | DL |
| X-linked lymphoproliferative disease due to SH2D1A deficiency | 0.9813 | DL |
| Cushing disease due to pituitary adenoma | 0.9809 | DL |
| lysosomal acid lipase deficiency | 0.9798 | DL |
| metachromatic leukodystrophy | 0.9797 | DL |
| skeletal muscle disease | 0.9794 | DL |
| Steel syndrome | 0.9782 | DL |
| inclusion myopathy | 0.9770 | DL |
| alpha-mannosidosis | 0.9759 | DL |
| A20 haploinsufficiency | 0.9752 | DL |
| immune dysregulation with inflammatory bowel disease | 0.9732 | DL |
| syndromic neurometabolic disease with X-linked intellectual disability | 0.9730 | DL |
| recessive X-linked ichthyosis | 0.9728 | DL |
| lysosomal disease with hypertrophic cardiomyopathy | 0.9728 | DL |
| infantile neuronal ceroid lipofuscinosis | 0.9711 | DL |
| eyelids malposition disorder | 0.9706 | DL |
| free sialic acid storage disease | 0.9701 | DL |
| Sanfilippo syndrome | 0.9700 | DL |
| Gaucher disease perinatal lethal | 0.9693 | DL |
| gangliosidosis | 0.9684 | DL |
| familial encephalopathy with neuroserpin inclusion bodies | 0.9666 | DL |
| ptosis-vocal cord paralysis syndrome | 0.9649 | DL |
| congenital Horner syndrome (disease) | 0.9644 | DL |
| camptodactyly, myopia, and fibrosis of the medial rectus muscle of eye | 0.9641 | DL |
| ptosis-strabismus-ectopic pupils syndrome | 0.9632 | DL |
| Fabry disease | 0.9626 | DL |
| lipase deficiency, combined | 0.9623 | DL |
| ptosis-upper ocular movement limitation-absence of lacrimal punctum syndrome | 0.9620 | DL |
| hypophosphatasia | 0.9620 | DL |
| myoclonic epilepsy, juvenile, susceptibility to | 0.9619 | DL |
| familial restrictive cardiomyopathy | 0.9618 | DL |
| adolescent/adult-onset epilepsy syndrome | 0.9617 | DL |
| cholesterol metabolism disease | 0.9612 | DL |
| neuronal ceroid lipofuscinosis 8 northern epilepsy variant | 0.9608 | DL |
| jaw-winking syndrome | 0.9603 | DL |
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.